Tag : pharmaceuticals

Pediatrics

St. Jude experimental anti-malarial drug shows promise in first clinical trial

Newsemia
Malaria is a leading killer of children worldwide, and new drugs are needed. New research reports encouraging early clinical results with a new compound. Source...
Latest News

Alnylam Pharmaceuticals et Gen signent un accord de distribution en Turquie pour ONPATTRO® (patisiran), le meilleur agent iARN de silençage génique actuellement disponible

Newsemia
ZOUG, Suisse, et ANKARA, Turquie–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), le chef de file des agents thérapeutiques iARN, et Gen, une société pharmaceutique certifiée BPF...
Latest News

Cigna’s new Medicare Advantage chief talks about growth plans, Covid-19

Newsemia
Dr. Gina Conflitti was named chief medical officer of Cigna’s Medicare Advantage business on March 5. In her first month on the job, she shared...
AI/ML

“Inactive” pill ingredients could raise the dose of your medication

Newsemia
The average medication contains a mix of eight “inactive” ingredients added to pills to make them taste better, last longer, and stabilize the active ingredients within. Some...
Latest News

Kala Pharmaceuticals Announces Statistically Significant Results for Primary and Key Secondary Endpoints in STRIDE 3 Clinical Trial Evaluating EYSUVIS™ for Signs and Symptoms of Dry Eye Disease

Newsemia
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye,...
Latest News

Global Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio

Newsemia
LONDON–(BUSINESS WIRE)– #GlobalPosttraumaticStressDisorderTherapeuticsMarket–The post-traumatic stress disorder therapeutics market will grow by USD 909.86 million during 2020-2024 Source link...
Latest News

BMS, Voluntis partner on digital therapeutics for cancer patients

Newsemia
The companies will develop a mobile app that will allow patients to self-manage symptoms and enable remote monitoring by healthcare providers. In a phone interview,...
Latest News

Startup raises $15M to help prevent and treat opioid addiction

Newsemia
AxialHealthcare, a startup building software to manage opioid prescriptions and addiction, raised $15 million in funding. The company plans to use the new funds to...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy